Leading Executives Once Again Meet at GDS International’s Next Generation Pharmaceutical Manufacturing Europe Summit to Discuss Key Objectives For The Industry

...BRISTOL England November 29 2011 /- ...- The Next Generation Pharmaceutical Manufacturing Summit ...Next Generation Pharmaceutical Manufacturing Europe will take place fr...The summit has elected more than 50 of the most well respected executi...

Next Generation Pharmaceutical Manufacturing Europe will take place from 6th - 8th December in Barcelona, Spain and will provide leading executives with an ideal framework for new business relationships to flourish.

The summit has elected more than 50 of the most well respected executives in the European pharmaceutical industry. Speakers will include Bo Hilligsøe, VP Finished Goods Production, H.Lundbeck; Bart Moors, Director of Business & Project Development Life Science at Siemens; Philippe Gerwill, Head Global IT Purchasing, Novartis; and many more. Sponsors include leading companies such as Pegasus, Lodestone, and Corden Pharma amongst others.

The summit will see senior level executives from drug manufacturing companies across Europe meet to discuss key objectives for the industry.

Fabrizio Borin, Head of Production at Lundbeck Pharmaceuticals Italy, said of June's Pharma Manufacturing event, "It was a relaxed environment in which you have the chance to talk together, exchange ideas, and network. It was a very, very good experience."

As well as comprehensive workshops, the summit involves panel discussions offering executives moderated, peer-led discussions on major industry issues. One-to-one meetings will give delegates the chance to meet with business analysts and analyst partners to discuss pressing issues for the industry.

A total of 16 workshops will cover sustainable business strategy, best practices for optimising manufacturing processes, virtualisation, maximising supply chain efficiency, and much more.

Gareth Jones, Summit Director at GDS International - the global business event company behind NG Pharmaceutical Manufacturing US - says, "Our high caliber of speakers and exciting content, combined with fantastic opportunities for networking, give our delegates and sponsors real value for money and return on their investment and ensures that NG Pharma Manufacturing stands out against other events."

GDS International is one of the most innovative events and media companies worldwide and a globally renowned producer of business-to-business summits, conferences, online information and advisory group gatherings.

Founded in 1993, GDS International specialises in meeting the B2B marketing needs of our clients. Having a strong presence in mature industrial sectors but a finger on the pulse of emerging markets - as well as up-and-coming B2B business verticals - means we are perfectly placed to capitalise on the exciting developments brought about by the advent of a globalised economy.

(Date:12/8/2016)... -- KEY FINDINGS North America ... in 2016 and is expected to continue in the ... large number of surgical procedures that are taking place ... the patient temperature management market.) Patient warming and cooling ... blood during surgeries, lowering the risks of neurological disorders ...

(Date:12/8/2016)... Dec. 8, 2016 Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...

(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia ... 1, 2017. The name change aligns the entire company with its existing ... care quality. , “We are very proud of the achievements associated with the ...